Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

NCT00384891 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

190

Enrollment

INDUSTRY

Sponsor class

Stopped slow accrual

Conditions

Urinary Bladder Diseases
Urinary Bladder Neoplasms
Urinary Bladder Cancer
Malignant Tumor of Urinary Bladder
Urologic Diseases
Urologic Neoplasms
Neoplasms
Neoplasms by Site

Interventions

DEVICE: Synergo + MMC
DRUG: Bacillus Calmette-Guérin

Sponsor

Medical Enterprises Europe B.V.